☆ 4.7 Meeting Abstract

Treatment with spesolimab, an anti-interleukin-36 receptor antibody, in patients with generalized pustular psoriasis, is associated with the downregulation of biomarkers linked to innate, Th1/17 and neutrophilic pathways

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)

Get Full Text
Add to Collection

Journal

JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 139, Issue 9, Pages S281-S281

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jid.2019.07.390

Keywords

-

Categories

Dermatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.